- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01365715
Preoperative Embolization in Surgical Treatment of Spinal Metastases.
February 25, 2014 updated by: Caroline Clausen, Rigshospitalet, Denmark
Preoperative Embolization in Surgical Treatment of Spinal Metastases. A Randomized Controlled Trial.
The main purpose of this study is to assess the efficacy of preoperative embolization in decreasing operative blood loss, decreasing the need for intraoperative transfusion and facilitate surgical resection in metastatic spine surgery.
Furthermore the study aims at describing the vascularity in a series of spinal metastasis, and to correlate this with perioperative blood loss.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
48
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Copenhagen, Denmark, 2100
- Department of Radiology, Rigshospitalet
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients scheduled for decompression and posterior thoracic and/or lumbar instrumented spinal fusion because of spinal metastasis/metastases.
- Informed signed consent.
Exclusion Criteria:
- Contrast fluid allergy.
- Clotting disorders.
- Renal failure.
- Not suitable for arterial access.
- Pregnancy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Preoperative embolization
32 patients with spinal metastasis/metastases will undergo arteriography and receive transcatheter arterial embolization of spinal metastasis/metastases 0-48 hours prior to surgery.
|
Arteriography and transcatheter arterial embolization of spinal metastasis/metastases 0-48 hours prior to surgery.
Other Names:
|
|
ACTIVE_COMPARATOR: Control group
32 patients with spinal metastasis/metastases will undergo arteriography of spinal metastasis/metastases without receiving transcatheter arterial embolization prior to surgery.
|
Arteriography of spinal metastasis/metastases without transcatheter arterial embolization prior to surgery.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Perioperative blood loss
Time Frame: Measured intraoperatively and 24 hours postoperatively.
|
Measured intraoperatively and 24 hours postoperatively.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perioperative blood transfusion volume
Time Frame: Intraoperatively and until 48 hours postoperatively.
|
Intraoperatively and until 48 hours postoperatively.
|
|
|
Surgical procedure time.
Time Frame: At skin closure.
|
Defined as the amount of time (measured in minutes) from skin incision to skin closure.
|
At skin closure.
|
|
Vascularization grade of metastasis
Time Frame: At the angiographic procedure prior to embolization performed 0-48 hours before surgery.
|
At the angiographic procedure prior to embolization performed 0-48 hours before surgery.
|
|
|
Success of embolization
Time Frame: Directly after the embolization performed 0-48 hours before surgery.
|
Directly after the embolization performed 0-48 hours before surgery.
|
|
|
Adverse events related to angiography or embolization
Time Frame: Within 2 postoperative days
|
Within 2 postoperative days
|
|
|
Adverse events related to surgery
Time Frame: Within 2 postoperative days
|
Within 2 postoperative days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Lars Lönn, MD, Ph.d., Department of Radiology, Rigshospitalet. Copenhagen, Denmark.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2011
Primary Completion (ACTUAL)
February 1, 2014
Study Completion (ACTUAL)
February 1, 2014
Study Registration Dates
First Submitted
May 27, 2011
First Submitted That Met QC Criteria
June 1, 2011
First Posted (ESTIMATE)
June 3, 2011
Study Record Updates
Last Update Posted (ESTIMATE)
February 26, 2014
Last Update Submitted That Met QC Criteria
February 25, 2014
Last Verified
February 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-2-2011-024 (OTHER: The Danish Committee on Biomedical Research Ethics)
- 2008-41-2128 (OTHER: Danish Dataprotection Agency)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Metastases
-
Institute of Oncology LjubljanaRecruitingBone Metastases | Spinal Metastases | Spinal TumorsSlovenia
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnAdult Spinal Cord Neoplasm | Spinal Bone Metastases | Spinal Cord Metastases
-
City of Hope Medical CenterNational Cancer Institute (NCI)TerminatedAdult Spinal Cord Neoplasm | Spinal Bone Metastases | Spinal Cord Metastases | Recurrent Adult Spinal Cord NeoplasmUnited States
-
Rigshospitalet, DenmarkCompletedSpinal MetastasesDenmark
-
Baptist Health South FloridaRecruitingSpine MetastasesUnited States
-
Stanford UniversityRecruitingSpinal MetastasesUnited States
-
University Health Network, TorontoRecruiting
-
UMC UtrechtRadboud University Medical CenterRecruitingSpinal MetastasesNetherlands
-
M.D. Anderson Cancer CenterElekta LimitedActive, not recruitingSpinal MetastasesUnited States
-
Canadian Cancer Trials GroupTrans Tasman Radiation Oncology GroupCompletedSpinal MetastasesCanada, Australia
Clinical Trials on Arteriography and preoperative embolization
-
Peking University People's HospitalNot yet recruitingPelvic Tumor | Embolization
-
Fundación para la Investigación del Hospital Clínico...CompletedEsophageal Anastomotic Leak | Tissue Pressure of OxygenSpain
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingCholangiocarcinoma Non-resectable
-
University Hospital, BordeauxRecruiting
-
Centre Hospitalier Universitaire de NiceCompleted
-
Guangxi Medical UniversityUnknownHepatoCellular CarcinomaChina
-
Scynexis, Inc.Completed
-
Shanghai Bomaian Medical Technology Co., LtdNot yet recruitingPeripheral Arterial DiseaseChina
-
Odense University HospitalCompleted
-
Societe Francaise de RhumatologieCentre Hospitalier Universitaire de Nice; Euraxi PharmaRecruitingKnee Pain Chronic | Knee Pain SwellingFrance